CTOs on the Move

Axonics Modulation Technologies

www.axonics.com

 
Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable IPG licensed from the Alfred Mann Foundation. The Axonics Sacral Neuromodulation System is designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million
  • www.axonics.com
  • 7575 Irvine Center Drive Suite 200
    Irvine, CA USA 92618
  • Phone: 949.396.6322

Executives

Name Title Contact Details

Funding

Axonics Modulation Technologies raised $38.5M on 12/22/2015
Axonics Modulation Technologies raised $14.5M on 05/02/2017
Axonics Modulation Technologies raised $20.5M on 07/06/2017
Axonics Modulation Technologies raised $20M on 04/03/2018
Axonics Modulation Technologies raised $110M on 11/22/2019
Axonics Modulation Technologies raised $17M on 12/13/2019
Axonics Modulation Technologies raised $201.3M on 05/14/2021

Similar Companies

Atrium Medical Corporation

Founded in 1981, Atrium is a diversified healthcare provider where improved patient outcomes is job one for every member of the firm. From Hudson, NH to Mosman (Sydney), Australia or Mijdrecht, The Netherlands, service and workmanship in the quality

Swiss-American Products dba as elta Skin and Wounc Care

Swiss-American Products dba as elta Skin and Wounc Care is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Scilabs Nutracueticals

Scilabs Nutracueticals is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Horschel Brothers Precision

Horschel Brothers Precision is a Springville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Instrument Development Inc

Advanced Instrument Development Inc is a Downers Grove, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.